Abstract
Background: Ketamine is an anesthetic compound that has recreational use and can cause heart-related toxicity, different psychiatric disorder, and even death. Nevertheless, the management of ketamine overdose is not yet perfect. Hence, the discovery or identification of compounds that can manage ketamine overdose is essential. Ketamine can induce schizophrenia and lurasidone can treat schizophrenia, on its basis, the present study was aimed to determine if lurasidone can alter ketamine-induced death and/or reduce recovery time from ketamine-induced anesthesia. Methods: Mice were initially injected with 50 mg/kg, 100mg/kg, 150mg/kg, and 200mg/kg i.p. ketamine for toxicity test, and any death was recorded. Based on the toxicity study, the lethal dose was determined (150mg/kg b.w.) and further administered intra-peritoneally to fresh mice groups followed by treatment with 0.5mg/kg, 1mg/kg, 2mg/kg lurasidone. Afterward, survival rate and recovery time were recorded. Results: Control (only ketamine) treated mice group showed only 20% survival, whereas all three doses of lurasidone were able to keep all of the mice alive. However, no significant difference was found between the applied doses of lurasidone. In addition, all three doses of lurasidone minimized recovery time compared to control in a dose-dependent manner. The fastest recovery time recorded was 54 minutes by 2 mg/kg of lurasidone-pretreated mice. Conclusion: Although lurasidone was able to reduce ketamine-induced mortality rate and recovery time, the mechanism of lurasidone by which it exhibits recovery against ketamine is yet to be explored.